Cantley elected as board chair of Hope Funds
Meyer director Lewis Cantley, Ph.D., was recently elected as Chairman of the Board of Trustees of the Hope Funds for Cancer Research, a charity dedicated to advancing innovative research for the most difficult-to-treat cancers.
"Dr. Cantley is an outstanding choice to lead the Hope Funds for Cancer Research Board of Trustees," said Leah Rush Cann, a Hope Funds founder and Chair of its Executive Committee. "His achievements in basic and clinical science along with his expertise in mentoring young scientists make him ideally suited for the role. He has known the organization as a mentor, speaker, and honoree and now can combine those experiences to lead Hope Funds for Cancer Research into its next decade."
The Hope Funds for Cancer Research is dedicated to finding outstanding cancer discoveries by funding outstanding young cancer researchers. The organization was formed in 2006 to establish a philanthropic vehicle that would take a rational scientific, medical, and investment approach to making grants for the most innovative and promising research efforts to address the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, renal and ovarian cancers, as well as rare leukemias, lymphomas and MDS.
Dr. Cantley was honored by the organization last year with a Hope Funds for Cancer Research Award of Excellence.